The pharmacologic treatment of depression: Is gender a critical factor?

Journal of Clinical Psychiatry

Volumn 63, Issue 7, 2002, Pages 610-615

  Yonkers, Kimberly A ^a   Brawman Mintzer, Olga ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CHLORPROMAZINE; CLOMIPRAMINE; CYTOCHROME P450 1A2; CYTOCHROME P450 3A; DESIPRAMINE; DIAZEPAM; FLUOXETINE; HYDROXYNEFAZODONE; IMIPRAMINE; NEFAZODONE; NORTRIPTYLINE; ORAL CONTRACEPTIVE AGENT; PAROXETINE; PENTOBARBITAL; PHENELZINE; PROGESTERONE; SEROTONIN 2 RECEPTOR; SERTRALINE; TACRINE; TRIAZOLAM;

DEPRESSION; DRUG CLEARANCE; DRUG EFFICACY; DRUG HYDROXYLATION; DRUG METABOLISM; DYSTHYMIA; ENZYME ACTIVITY; FOOD AND DRUG ADMINISTRATION; GENETIC POLYMORPHISM; HORMONE SUBSTITUTION; HUMAN; MEDLINE; PHARMACODYNAMICS; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; SEX DIFFERENCE; SIDE EFFECT;

EID: 0036073794     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v63n0714     Document Type: Review

References (66)

1. Underrepresentation of women in new drug trials: Ramifications and remedies
2. Women in clinical trials of new drugs: A change in Food and Drug Administration policy
3. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
4. Sex differences in recurrent depression: Are there any that are significant?
5. Columbia atypical depression: A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo
6. Gender difference in response to treatment of depression
7. Forms of atypical depression and their response to antidepressant drugs
8. Transdermal oestrogen for treatment of severe postnatal depression
9. Prophylactic estrogen in recurrent postpartum affective disorder
10. Estrogen replacement in perimenopause-related depression: A preliminary report
11. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women
12. Modulation of monoamine neurotransmitters by estrogen: Clinical implications
13. Sex differences in psychopharmacology
14. Gender differences in pharmacokinetics and pharmacodynamics of psychotropics: Focus on women
15. The menstrual cycle in context, 1: Affective syndromes associated with reproductive hormonal changes
16. Sex differences in metabolism and pharmacokinetics: Effects on agent choice and dosing
17. Gender effects in pharmacokinetics and pharmacodynamics
18. Gender differences in psychotropic drug metabolism
19. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication
20. The P450 superfamily: Update on new sequences, gene mapping and recommended nomenclature
21. Sex differences in pharmacokinetics of psychotropic medications, part 2: Effects on selected psychotropics
22. Effect of age and gender on the activity of human hepatic CYP3A
23. Drug metabolism by cytochromes P450 in the liver and small bowel
24. Frequency distribution of dapsone N-hydroxylase, a putative probe for P4503A4 activity in a white population
25. Nonlinear pharmacokenefics of fluvoxamine and gender differences
26. Serum concentrations of tacrine hydrochloride predict its adverse effects in Alzheimer's disease
27. Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: Relationship to the CYP2D6 genotype
28. Plasma levels of imipramine and desmethylimipramine during therapy
29. Plasma levels of amitriptyline: Effects of age and sex
30. Clomipramine metabolism: Model based analysis of variability factors from drug monitoring data
31. Tricyclic plasma levels: Effects of age, race, sex, and smoking
32. Are gender differences in antiobsessional response related to different clomipramine metabolism?
33. Single-dose kinetics of clomipramine: Relationship to the sparteine and S-mephenytoin oxidation polymorphisms
34. The influence of age and gender on the stereoselective metabolism and pharmacokinetics of mephobarbital in humans
35. Impairment of diazepam metabolism by low-dose estrogen-containing oral-contraceptive steroids
36. Menstrual cycle effects on caffeine elimination in the human female
37. Inhibition of caffeine metabolism by estrogen replacement therapy in postmenopausal women
38. Imipramine and desipramine disposition in the elderly
39. Clinical implications of the pharmacology of sertraline
40. Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers
41. A study of the effect of age and gender on the pharmacokinetics of nefazodone after single and multiple doses
42. Gender differences in treatment response to sertraline versus imipramine in chronic depression
43. Sex-related variations in the frequency and characteristics of adverse drug reactions
44. Using the Adverse Reactions Register to study the effects of age and sex on adverse drug reactions
45. Improvement in pain and bowel function in female irritable bowel syndrome patients with alosetron, a 5-HT3 receptor antagonist
46. Differences between males and females in rates of serotonin synthesis in human brain
47. Age-sex differences in response to antidepressant drugs
48. Sex and the treatment of depressions: When does it matter?
49. Antidepressant response to paroxetine by gender
50. Fluoxetine vs tricyclic antidepressants in women with major depressive disorder
51. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial
52. Estrogen replacement therapy status and antidepressant response to sertraline
53. Modulation by estradiol of serotonin 1 receptors in brain
54. Estrogen control of central neurotransmission: Effect on mood, mental state, and memory
55. The menstrual cycle and platelet 5-HT uptake
56. Seasonal variations in binding of h-paroxetine to blood platelets in healthy volunteers: Indications for a gender difference
57. Colocalization of progestin receptors with serotonin in raphe neurons of macaque
58. Pituitary and brain actions of estrogen and progesterone in the regulation of primate prolactin secretion
59. Steroid regulation of estrogen and progestin receptor messenger ribonucleic acid in monkey hypothalamus and pituitary
60. Effect of progesterone on serotonin turnover in rats primed with estrogen implants into the ventromedial hypothalamus
61. Pharmacodynamic evaluation of the benzodiazepine-oral contraceptive interaction
62. Progesterone: Does it affect response to drug?
63. Orally administered progesterone enhances sensitivity to triazolam in postmenopausal women